It has been demonstrated that SOX2 suppresses cell migration and the invasion of gastric cancers (GCs), and its low expression, frequently seen in GCs, is strongly associated with poor outcomes for GC patients [13]. The gene discussed is SOX2; the disease is gastric cancer.